Statements (73)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Genetics
|
| gptkbp:applies_to |
early-stage breast cancer
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:developed_by |
gptkb:Genomic_Health
|
| gptkbp:evaluates |
tumor biology
|
| gptkbp:facilitates |
shared decision-making
|
| gptkbp:first_introduced |
gptkb:2004
|
| gptkbp:has_achieved |
risk of recurrence
|
| gptkbp:helps_determine |
chemotherapy benefit
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oncotype DX
|
| gptkbp:is_a_guide_for |
adjuvant therapy
surgical decisions |
| gptkbp:is_analyzed_in |
pathologists
low-risk patients lymph node involvement |
| gptkbp:is_associated_with |
improved outcomes
quality of life improvements treatment de-escalation |
| gptkbp:is_available_for |
gptkb:hormone_receptor-positive_breast_cancer
|
| gptkbp:is_based_on |
RT-PCR technology
|
| gptkbp:is_compared_to |
other genomic tests
|
| gptkbp:is_considered |
gptkb:guidelines
clinical studies patient counseling treatment planning standard of care treatment optimization treatment pathways |
| gptkbp:is_discussed_in |
gptkb:literature
patient education materials |
| gptkbp:is_evaluated_by |
clinical utility
patient outcomes clinical practice cost-effectiveness healthcare settings long-term outcomes |
| gptkbp:is_influenced_by |
patient characteristics
|
| gptkbp:is_informed_by |
treatment decisions
genetic profiling |
| gptkbp:is_integrated_with |
multidisciplinary care
|
| gptkbp:is_linked_to |
personalized treatment plans
patient survival rates improved treatment adherence reduced overtreatment |
| gptkbp:is_part_of |
gptkb:Oncology
precision medicine breast cancer research breast cancer screening cancer care continuum breast cancer treatment guidelines breast cancer diagnostics breast cancer guidelines |
| gptkbp:is_promoted_by |
patient advocacy groups
|
| gptkbp:is_recognized_by |
gptkb:healthcare_professionals
|
| gptkbp:is_recommended_by |
gptkb:NCCN
|
| gptkbp:is_subject_to |
research studies
|
| gptkbp:is_supported_by |
insurance providers
clinical evidence |
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:is_used_in |
clinical trials
|
| gptkbp:is_utilized_by |
oncologists
|
| gptkbp:is_utilized_in |
multidisciplinary teams
patient stratification breast cancer management |
| gptkbp:measures |
expression of genes
|
| gptkbp:monitors |
treatment response
|
| gptkbp:performed_in |
tumor tissue samples
|
| gptkbp:provides |
recurrence score
|
| gptkbp:suitable_for |
metastatic breast cancer
|
| gptkbp:supports |
clinical decisions
|
| gptkbp:used_for |
gptkb:Oncology
|
| gptkbp:bfsParent |
gptkb:Genomic_Health
|
| gptkbp:bfsLayer |
6
|